Bayer and Recursion focus research collaboration on Oncology

November 9, 2023 UCBN News, Syndication Comments Off on Bayer and Recursion focus research collaboration on Oncology

BERLIN & SALT LAKE CITY–(BUSINESS WIRE)–Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that they have updated the focus of their research collaboration to precision oncology. The oncology-focused collaboration will leverage Bayer’s small molecule compound library and expertise in…
Click here to view original post

Related Articles

No Picture
News

HEALTHCARE AND TECH LEADERS COME TOGETHER TO ARCHITECT A BETTER PATIENT PORTRAIT AT THE 2022 HIT CONFERENCE

November 7, 2022 UCBN News Comments Off on HEALTHCARE AND TECH LEADERS COME TOGETHER TO ARCHITECT A BETTER PATIENT PORTRAIT AT THE 2022 HIT CONFERENCE

KEYNOTES BY BRITTANY BOWE (SPEED SKATER, 3-TIME OLYMPIAN) AND RICH SAUNDERS (CHIEF INNOVATION OFFICER, STATE OF UTAH) SPEAKERS FROM NATIONAL AND LOCAL ORGANIZATIONS: OFFICE OF THE NATIONAL COORDINATOR FOR HEALTH INFORMATION TECHNOLOGY (ONC); UNIVERSITY OF […]

No Picture
News

Orpyx Medical Technologies Supplies Digital Health Platform for NIH-Funded and Johns Hopkins Medicine–Led Clinical Trial on Diabetic Foot Ulcer Prevention

November 13, 2025 UCBN News, Syndication Comments Off on Orpyx Medical Technologies Supplies Digital Health Platform for NIH-Funded and Johns Hopkins Medicine–Led Clinical Trial on Diabetic Foot Ulcer Prevention

CALGARY, Alberta–(BUSINESS WIRE)–Orpyx® Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health (NIH). The WIREDUP: […]